InotivNOTVQ -9.91% EV-to-FCF is -34.74 as of Jun. 24, 2026. The stock has 4 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, Inotiv ranks worse than 1020407.14% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Inotiv's Enterprise Value is $472.9 Mil.
Inotiv's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-13.6 Mil. Therefore, Inotiv's EV-to-FCF for today is -34.74.
The historical rank and industry rank for Inotiv's EV-to-FCF or its related term are showing as below:
NOTVQ'
s EV-to-FCF Range Over the Past 10 Years
Min: -577.6 Med: -13.11 Max: 1832.63
Current: -34.74
During the past 13 years, the highest EV-to-FCF of Inotiv was 1832.63. The lowest was -577.60. And the median was -13.11.
NOTVQ's EV-to-FCF is ranked worse than 100% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.14
vs NOTVQ: -34.74
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-06-24), Inotiv's stock price is $0.01.
Inotiv's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.530. Therefore, Inotiv's PE Ratio (TTM) for today is At Loss.
Inotiv (OTCPK:NOTVQ) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inotiv's share price for today is $0.01.
Inotiv's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.530.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Inotiv EV-to-FCF Related Terms
Inotiv EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Inotiv's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Inotiv's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inotiv EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Inotiv's EV-to-FCF falls into.
Inotiv's current Enterprise Value is $472.9 Mil.
Inotiv's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inotiv (NOTVQ) has a EV-to-FCF of -34.74 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Inotiv and its competitors. According to the industry distribution chart, Inotiv ranks #999999 out of 98 companies in the Medical Diagnostics & Research industry.
Is Inotiv's EV-to-FCF too high?
Inotiv's current EV-to-FCF is -34.74. Based on the distribution chart, Inotiv ranks #999999 out of 98 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Inotiv's EV-to-FCF compare to NDRA and XWEL?
According to the Medical Diagnostics & Research industry distribution chart, Inotiv ranks #999999 out of 98 companies for EV-to-FCF. This places Inotiv in the lower half of its industry. The industry median EV-to-FCF is 22.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.14, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Inotiv and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inotiv's current EV-to-FCF is -34.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inotiv stock overvalued right now?
Based on GuruFocus' analysis, Inotiv (NOTVQ) is currently considered Possible Value Trap. The stock's GF Value™ is $1.68, compared to a current price of $0.01 — trading 99.4% below its estimated fair value. The current EV-to-FCF is -34.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Inotiv (NOTVQ), the current EV-to-FCF is -34.74 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NOTVQ has been successfully added to your 